Influence of subthalamic deep brain stimulation versus Levodopa on motor perseverations in Parkinson's disease

Movement Disorders

Volumn 24, Issue 8, 2009, Pages 1206-1210

  Herzog, Jan ^a   Möller, Bettina ^a   Witt, Karsten ^a   Pinsker, Marcus O ^a   Deuschl, Günther ^a   Volkmann, Jens ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Motor control; Neuropsychology; Random behavior; STN DBS; Vienna perseveration task

Indexed keywords

LEVODOPA;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LOCOMOTION; MALE; MORNING DOSAGE; MOTOR CONTROL; MOTOR PERFORMANCE; NERVE STIMULATION; PARKINSON DISEASE; PERSEVERATION; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS; TREATMENT RESPONSE;

AGED; ANTIPARKINSON AGENTS; DEEP BRAIN STIMULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOTOR ACTIVITY; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SUBTHALAMIC NUCLEUS;

EID: 67651146717     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22568     Document Type: Article

References (30)

1. Ebersbach G, Hattig H, Schelosky L, Wissel J, Poewe W. Perseverative motor behaviour in Parkinson's disease. Neuropsychologia 1994;32:799-804.
2. Stoffers D, Berendse HW, Deijen JB, Wolters EC. Motor perseveration is an early sign of Parkinson's disease. Neurology 2001; 57:2111-2113.
3. Jahanshahi M, Profice P, Brown RG, Ridding MC, Dirnberger G, Rothwell JC. The effects of transcranial magnetic stimulation over the dorsolateral prefrontal cortex on suppression of habitual counting during random number generation. Brain 1998;121 (Pt 8):1533-1544.
4. Benecke R, Rothwell JC, Dick JP, Day BL, Marsden CD. Disturbance of sequential movements in patients with Parkinson's disease. Brain 1987;110 (Pt 2):361-379.
5. Cools R, Barker RA, Sahakian BJ, Robbins TW. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 2001;11:1136-1143.
6. Gotham AM, Brown RG, Marsden CD. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain 1988;111 (Pt 2):299-321.
7. Hilker R, Voges J, Ghaemi M, et al. Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans. Mov Disord 2003;18:41-48.
8. Dehaene S, Tzourio N, Frak V, et al. Cerebral activations during number multiplication and comparison: a PET study. Neuropsychologia 1996;34:1097-1106.
9. Jahanshahi M, Dirnberger G, Fuller R, Frith CD. The role of the dorsolateral prefrontal cortex in random number generation: a study with positron emission tomography. Neuroimage 2000;12: 713-725.
10. Friston KJ, Frith CD, Liddle PF, Frackowiak RS. Investigating a network model of word generation with positron emission tomography. Proc Biol Sci 1991;244:101-106.
11. Frith CD, Friston KJ, Liddle PF, Frackowiak RS. A PET study of word finding. Neuropsychologia 1991;29:1137-1148.
12. Diamond A. Developmental time course in human infants and infant monkeys, and the neural bases of, inhibitory control in reaching. Ann NY Acad Sci 1990;608:637-669; discussion 669-676.
13. Deiber MP, Passingham RE, Colebatch JG, Friston KJ, Nixon PD, Frackowiak RS. Cortical areas and the selection of movement: a study with positron emission tomography. Exp Brain Res 1991;84:393-402.
14. Frith CD, Friston K, Liddle PF, Frackowiak RS. Willed action and the prefrontal cortex in man: a study with PET. Proc Biol Sci 1991;244:241-246.
15. Playford ED, Jenkins IH, Passingham RE, Nutt J, Frackowiak RS, Brooks DJ. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurol 1992;32:151-161.
16. Alexander GE. Basal ganglia-thalamocortical circuits: their role in control of movements. J Clin Neurophysiol 1994;11:420-431.
17. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trend Neurosci 1990;13:281-285.
18. Temel Y, Blokland A, Steinbusch HW, Visser-Vandewalle V. The functional role of the subthalamic nucleus in cognitive and limbic circuits. Prog Neurobiol 2005;76:393-413.
19. Limousin P, Greene J, Pollak P, Rothwell J, Benabid AL, Frackowiak R. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann Neurol 1997;42:283-291.
20. Stoffers D, Bosboom JL, Deijen JB, Wolters EC, Berendse HW, Stam CJ. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia. Brain 2007;130 (Pt 7):1847-1860.
21. Stoffers D, Bosboom JL, Deijen JB, Wolters ECh, Stam CJ, Berendse HW. Increased cortico-cortical functional connectivity in early-stage Parkinson's disease: an MEG study. Neuroimage 2008;41:212-222.
22. Mantini D, Perrucci MG, Del Gratta C, Romani GL, Corbetta M. Electrophysiological signatures of resting state networks in the human brain. Proc Natl Acad Sci USA 2007;104:13170-13175.
23. Benamer HT, Patterson J, Wyper DJ, Hadley DM, Macphee GJ, Grosset DG. Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake. Mov Disord 2000;15:692-698.
24. Carbon M, Ma Y, Barnes A, et al. Caudate nucleus: in.uence of dopaminergic input on sequence learning and brain activation in Parkinsonism. Neuroimage 2004;21:1497-1507.
25. Spiegel J, Hellwig D, Samnick S, et al. Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease. J Neural Transm 2007;114:331-335.
26. Schroeder U, Kuehler A, Haslinger B, et al. Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study. Brain 2002;125 (Pt 9): 1995-2004.
27. Cools R, Barker RA, Sahakian BJ, Robbins TW. L-Dopa medication remediates cognitive in.exibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 2003;41: 1431-1441.
28. Poewe W, Berger W, Benke T, Schelosky L. High-speed memory scanning in Parkinson's disease: adverse effects of levodopa. Ann Neurol 1991;29:670-673.
29. Frank MJ. Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive de.cits in medicated and nonmedicated Parkinsonism. J Cogn Neurosci 2005;17:51-72.
30. Gauntlett-Gilbert J, Roberts RC, Brown VJ. Mechanisms underlying attentional set-shifting in Parkinson's disease. Neuropsychologia 1999;37:605-616.